38 studies were found.

1.		Recruiting	Abciximab (ReoPro) in Acute Ischemic Stroke Condition: Stroke
2.		Recruiting	Alimta (pemetrexed) and Cisplatin versus Gemzar (gemcitabine) and Cisplatin in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Condition: Non Small Cell Lung Carcinoma
3.		Recruiting	ALIMTA (pemetrexed) and Gemcitabine (gemzar) in Patients with Advanced Cancer Condition: Neoplasms
4.		Recruiting	Alimta (pemetrexed) in Patients with Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy Condition: Non-Small-Cell Lung Carcinoma
5.		Recruiting	Alimta (pemetrexed) plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma Condition: Pleural Neoplasms
6.		Recruiting	ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have not had previous chemotherapy. Condition: Carcinoma, Non-Small-Cell Lung
7.		Recruiting	ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy Condition: Mesothelioma
8.		Recruiting	Alimta (pemetrexed) plus Gemzar (gemcitabine) in metastatic breast cancer patients after receiving Taxane therapy. Condition: Breast Cancer
9.		Recruiting	A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia Condition: Schizophrenia
10.		Recruiting	Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients with Schizophrenia and Schizoaffective Disorder Condition: Schizophrenia
11.		Not yet recruiting	Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia Condition: Schizophrenic Disorders
12.		Recruiting	Comparison of Intramuscular Olanzapine Depot with Placebo in the Treatment of Patients with Schizophrenia Condition: Schizophrenia
13.		Recruiting	Comparison of Study Drug With Alendronate on How it Effects Glucocorticoid-Induced Osteoporosis Condition: Osteoporosis
14.		Recruiting	Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer Condition: Osteoporosis, Postmenopausal
15.		Recruiting	Effects of Arzoxifene on Bone Mass and the Uterus Condition: Postmenopausal Bone Loss
16.		Recruiting	Effects of Teriparatide in Postmenopausal Women with Osteoporosis Previously Treated with Alendronate or Raloxifene Condition: Postmenopausal Osteoporosis
17.		Recruiting	Efficacy and Safety of LY451395 in Patients with Probable Alzheimer's Disease Condition: Alzheimer's Disease
18.		Recruiting	Efficacy and Safety of Olanzapine in Patients with Borderline Personality Disorder Condition: Borderline Personality Disorder
19.		Recruiting	Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers Conditions: Smoking; Depression
20.		Recruiting	Gemcitabine, Dexamethasone and Cisplatin Versus Dexamethasone, Cytarabine, Cisplatin in Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Condition: Lymphoma
21.		Recruiting	Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis Condition: Sepsis
22.		Recruiting	An Investigational Drug Compared to a Marketed Drug and Placebo in the Treatment of Patients with Depression Condition: Depression
23.		Recruiting	New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery Conditions: Total Knee Replacement; Total Hip Replacement
24.		Recruiting	Olanzapine Compared to Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I Disorder Condition: Bipolar Disorder
25.		Recruiting	Olanzapine in Patients with Borderline Personality Disorder Condition: Borderline Personality Disorder
26.		Recruiting	Olanzapine Versus Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder Condition: Bipolar Disorder
27.		Recruiting	Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial Condition: Major Depressive Disorder
28.		Not yet recruiting	An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder Condition: Schizophrenic Disorders
29.		Recruiting	Oral Enzastaurin HCl in Patients with Relapsed Mantle Cell Lymphoma Condition: Mantle-Cell Lymphoma
30.		Recruiting	Pharmacokinetic Characterization of Intramuscular Olanzapine Depot Conditions: Schizophrenia; Schizoaffective Disorder
31.		Recruiting	A Phase 1 Trial of ALIMTA (pemetrexed) in Patients With Locally Advanced or Metastatic Cancer Conditions: metastatic cancer; Cancer; Chemotherapy
32.		Recruiting	Prophylactic Heparin during Xigris [Drotrecogin Alfa (Activated)] Treatment of High-Risk Severe Sepsis Condition: Sepsis
33.		Recruiting	Reduction in the Occurrence of Center-Threatening Diabetic Macular Edema Condition: Diabetic Retinopathy
34.		Recruiting	The Study of Olanzapine Plus Fluoxetine in Combination for Treatment-Resistant Depression Without Psychotic Features Condition: Depressive Disorders
35.		Recruiting	Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia Condition: Schizophrenia
36.		Recruiting	A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. Condition: Non-Hodgkin's Lymphoma
37.		Recruiting	A study with Gemzar and LY293111 in patients with pancreatic cancer. Condition: Pancreatic Cancer
38.		Recruiting	Trial for First-Line Treatment of Colorectal Cancer Condition: Colorectal Cancer